| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 580.5 | 525.4 | 443.9 |
| Other income | 19.0 | 33.4 | 33.9 |
| Total income | 599.5 | 558.8 | 477.8 |
| Profit before exceptional items & tax | 115.9 | 117.3 | 121.7 |
| Exceptional items | 9.6 | 0.0 | 0.0 |
| Profit before tax | 125.5 | 117.3 | 121.7 |
| Net profit | 95.1 | 85.3 | 91.8 |
| Operating margin | 20.9% | 21.0% | 25.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +3.60% |
|---|---|
| Net profit, quarter on quarter | +11.50% |
| Revenue, year on year | +30.80% |
| Operating profit, year on year | +10.40% |
| Operating profit, quarter on quarter | +15.50% |
NSE results filing, NSE: POLYMED. Figures extracted from the filing.
Poly Medicure Ltd: key numbers
- Share price
- ₹1,607.60
- Market cap
- ₹16,295 Cr
- Revenue (annual)
- ₹1,875 Cr
- Net profit (annual)
- ₹322.1 Cr
- P/E (TTM)
- 51.7×Sector 54.5×
- Promoter holding
- 62.42%+0.00% QoQ
- FII holding
- 5.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Poly Medicure Ltd
All →Poly Medicure Other Announcement
Poly Medicure's board revised five governance policies and codes, including material subsidiary, materiality, related party transactions, and insider trading codes. The revised documents are published on the company website.
Poly Medicure Board Meeting Date
Poly Medicure will hold a board meeting on 05 November 2026 to consider unaudited results. Trading window stays closed until 07 November 2026.
Poly Medicure Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Poly Medicure Annual General Meeting
Poly Medicure conducted its 31st Annual General Meeting on September 5, 2026, via video conferencing. This filing provides a summary of the meeting's proceedings and agenda items.
Poly Medicure Annual Report
Poly Medicure has filed its Notice of the 31st Annual General Meeting and the Annual Report for the financial year ended March 31, 2026.
Poly Medicure Dividend
Poly Medicure has announced a record date of August 29, 2026, for a final dividend of ₹3.50 per equity share for FY 2025-26.